Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers

Pheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in can...

Full description

Bibliographic Details
Main Authors: Shahida K. Flores, Cynthia M. Estrada-Zuniga, Keerthi Thallapureddy, Gustavo Armaiz-Peña, Patricia L. M. Dahia
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/18/4602
id doaj-d890b64f56e8460a8547d54f13ea7c3e
record_format Article
spelling doaj-d890b64f56e8460a8547d54f13ea7c3e2021-09-25T23:49:33ZengMDPI AGCancers2072-66942021-09-01134602460210.3390/cancers13184602Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic DriversShahida K. Flores0Cynthia M. Estrada-Zuniga1Keerthi Thallapureddy2Gustavo Armaiz-Peña3Patricia L. M. Dahia4Department of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USADepartment of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USAPheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in cancer. In this review, we explore unique mechanisms of pheochromocytoma and paraganglioma initiation and management by drawing from recent examples involving rare mutations of hypoxia-related genes <i>VHL, EPAS1</i> and <i>SDHB</i>, and of a poorly known susceptibility gene, <i>TMEM127.</i> These models expand our ability to predict variant pathogenicity, inform new functional domains, recognize environmental-gene connections, and highlight persistent therapeutic challenges for tumors with aggressive behavior.https://www.mdpi.com/2072-6694/13/18/4602pheochromocytomasparagangliomasmutationssusceptibility genesdriver mutationshereditary
collection DOAJ
language English
format Article
sources DOAJ
author Shahida K. Flores
Cynthia M. Estrada-Zuniga
Keerthi Thallapureddy
Gustavo Armaiz-Peña
Patricia L. M. Dahia
spellingShingle Shahida K. Flores
Cynthia M. Estrada-Zuniga
Keerthi Thallapureddy
Gustavo Armaiz-Peña
Patricia L. M. Dahia
Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
Cancers
pheochromocytomas
paragangliomas
mutations
susceptibility genes
driver mutations
hereditary
author_facet Shahida K. Flores
Cynthia M. Estrada-Zuniga
Keerthi Thallapureddy
Gustavo Armaiz-Peña
Patricia L. M. Dahia
author_sort Shahida K. Flores
title Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
title_short Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
title_full Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
title_fullStr Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
title_full_unstemmed Insights into Mechanisms of Pheochromocytomas and Paragangliomas Driven by Known or New Genetic Drivers
title_sort insights into mechanisms of pheochromocytomas and paragangliomas driven by known or new genetic drivers
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2021-09-01
description Pheochromocytomas and paragangliomas are rare tumors of neural crest origin. Their remarkable genetic diversity and high heritability have enabled discoveries of bona fide cancer driver genes with an impact on diagnosis and clinical management and have consistently shed light on new paradigms in cancer. In this review, we explore unique mechanisms of pheochromocytoma and paraganglioma initiation and management by drawing from recent examples involving rare mutations of hypoxia-related genes <i>VHL, EPAS1</i> and <i>SDHB</i>, and of a poorly known susceptibility gene, <i>TMEM127.</i> These models expand our ability to predict variant pathogenicity, inform new functional domains, recognize environmental-gene connections, and highlight persistent therapeutic challenges for tumors with aggressive behavior.
topic pheochromocytomas
paragangliomas
mutations
susceptibility genes
driver mutations
hereditary
url https://www.mdpi.com/2072-6694/13/18/4602
work_keys_str_mv AT shahidakflores insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers
AT cynthiamestradazuniga insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers
AT keerthithallapureddy insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers
AT gustavoarmaizpena insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers
AT patricialmdahia insightsintomechanismsofpheochromocytomasandparagangliomasdrivenbyknownornewgeneticdrivers
_version_ 1717367885134823424